{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:19:59Z","timestamp":1773271199391,"version":"3.50.1"},"reference-count":44,"publisher":"Japan Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej16-0551","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T22:11:08Z","timestamp":1494886268000},"page":"695-703","source":"Crossref","is-referenced-by-count":10,"title":["Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases"],"prefix":"10.1507","volume":"64","author":[{"given":"Naoya","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"},{"name":"Laboratory for Clinical Investigation, Osaka University Hospital, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Nakaguchi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayaka","family":"Kawaguti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical Investigation, Osaka University Hospital, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Iwatani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Iwatani Y, Watanabe M (1999) Normal Mechanisms for self-tolerance. In: Volpe, R. (ed). Autoimmune endocrinopathies. Humana Press, Inc. Totawa: 1-30.","DOI":"10.1007\/978-1-59259-704-8_1"},{"key":"2","unstructured":"2. Davies T (2000) Pathogenesis of Graves&rsquo; disease. In: Braverman LE., Utiger RD (ed). The thyroid - a Fundamental and Clinical Text. Lippincott Williams &amp; Wilkins. Philadelphia: 518-531."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, <i>et al<\/i>. (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. <i>Science<\/i> 254: 279-282.","DOI":"10.1126\/science.1681588"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. <i>Immunol Today<\/i> 17: 138-146.","DOI":"10.1016\/0167-5699(96)80606-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. <i>Nature<\/i> 383: 787-793.","DOI":"10.1038\/383787a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, <i>et al<\/i>. (2007) Phenotypic and functional features of human Th17 cells. <i>J Exp Med<\/i> 204: 1849-1861.","DOI":"10.1084\/jem.20070663"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. <i>Nat Immunol<\/i> 8: 345-350.","DOI":"10.1038\/ni0407-345"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nanba T, Watanabe M, Inoue N, Iwatani Y (2009) Increases of the Th1\/Th2 cell ratio in severe Hashimoto&rsquo;s disease and in the proportion of Th17 cells in intractable Graves&rsquo; disease. <i>Thyroid<\/i> 19: 495-501.","DOI":"10.1089\/thy.2008.0423"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Watanabe M, Yamamoto N, Maruoka H, Tamai H, Matsuzuka F, <i>et al<\/i>. (2002) Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto\u2019s disease. <i>Thyroid<\/i> 12: 801-808.","DOI":"10.1089\/105072502760339370"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y (2006) Association between the severity of Hashimoto&rsquo;s disease and the functional +874A\/T polymorphism in the interferon-gamma gene. <i>Endocr J<\/i> 53: 473-478.","DOI":"10.1507\/endocrj.K06-015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Morita M, Watanabe M, Inoue N, Inaoka C, Akamizu T, <i>et al<\/i>. (2012) Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves&rsquo; disease. <i>Autoimmunity<\/i> 45: 129-136.","DOI":"10.3109\/08916934.2011.622013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Igarashi O, Yanagida T, Azuma M, Okumura K, Nariuchi H (1996) B7-1 synergizes with interleukin-12 in interleukin-2 receptor alpha expression by mouse T helper 1 clones. <i>Eur J Immunol<\/i> 26: 300-306.","DOI":"10.1002\/eji.1830260205"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, <i>et al<\/i>. (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. <i>J Immunol<\/i> 153: 1697-1706.","DOI":"10.4049\/jimmunol.153.4.1697"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yilmaz V, Yentur SP, Saruhan-Direskeneli G (2005) IL-12 and IL-10 polymorphisms and their effects on cytokine production. <i>Cytokine<\/i> 30: 188-194.","DOI":"10.1016\/j.cyto.2005.01.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G (2002) A TaqI polymorphism in the 3&rsquo;UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. <i>Genes Immun<\/i> 3: 419-423.","DOI":"10.1038\/sj.gene.6363919"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bergholdt R, Ghandil P, Johannesen J, Kristiansen OP, Kockum I, <i>et al<\/i>. (2004) Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. <i>J Med Genet<\/i> 41: e39.","DOI":"10.1136\/jmg.2003.010454"},{"key":"17","unstructured":"17. Alifirova VM, Orlova I, Babenko SA, Rudko AA, Puzyrev VP (2006) The 1188 A\/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region. <i>Zh Nevrol Psikhiatr Im S S Korsakova<\/i> Spec No 3: 130-135 (In Russian)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamamoto K, Kobayashi H, Miura O, Hirosawa S, Miyasaka N (1997) Assignment of IL12RB1 and IL12RB2, interleukin-12 receptor beta 1 and beta 2 chains, to human chromosome 19 band p13.1 and chromosome 1 band p31.2, respectively, by in situ hybridization. <i>Cytogenet Cell Genet<\/i> 77: 257-258.","DOI":"10.1159\/000134589"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Akahoshi M, Nakashima H, Miyake K, Inoue Y, Shimizu S, <i>et al<\/i>. (2003) Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. <i>Hum Genet<\/i> 112: 237-243.","DOI":"10.1007\/s00439-002-0873-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Stoll S, Jonuleit H, Schmitt E, Muller G, Yamauchi H, <i>et al<\/i>. (1998) Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. <i>Eur J Immunol<\/i> 28: 3231-3239.","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, <i>et al<\/i>. (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. <i>Nature<\/i> 378: 88-91.","DOI":"10.1038\/378088a0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Puren AJ, Razeghi P, Fantuzzi G, Dinarello CA (1998) Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures. <i>J Infect Dis<\/i> 178: 1830-1834.","DOI":"10.1086\/314481"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, <i>et al<\/i>. (1995) A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. <i>Infect Immun<\/i> 63: 3966-3972.","DOI":"10.1128\/IAI.63.10.3966-3972.1995"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, <i>et al<\/i>. (1996) IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. <i>J Immunol<\/i> 157: 3967-3973.","DOI":"10.4049\/jimmunol.157.9.3967"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wild JS, Sigounas A, Sur N, Siddiqui MS, Alam R, <i>et al<\/i>. (2000) IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. <i>J Immunol<\/i> 164: 2701-2710.","DOI":"10.4049\/jimmunol.164.5.2701"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Giedraitis V, He B, Huang WX, Hillert J (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. <i>J Neuroimmunol<\/i> 112: 146-152.","DOI":"10.1016\/S0165-5728(00)00407-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, <i>et al<\/i>. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. <i>Arthritis Rheum<\/i> 25: 1271-1277.","DOI":"10.1002\/art.1780251101"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Montminy M (1997) Transcriptional regulation by cyclic AMP. <i>Annu Rev Biochem<\/i> 66: 807-822.","DOI":"10.1146\/annurev.biochem.66.1.807"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, <i>et al<\/i>. (2006) IL-18 gene polymorphisms affect IL-18 production capability by monocytes. <i>Biochem Biophys Res Commun<\/i> 342: 1413-1416.","DOI":"10.1016\/j.bbrc.2006.02.096"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, <i>et al<\/i>. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. <i>Nature<\/i> 415: 536-541.","DOI":"10.1038\/415536a"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Anderson AC, Anderson DE (2006) TIM-3 in autoimmunity. <i>Curr Opin Immunol<\/i> 18: 665-669.","DOI":"10.1016\/j.coi.2006.09.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Koguchi K, Anderson DE, Yang L, O&rsquo;Connor KC, Kuchroo VK, <i>et al<\/i>. (2006) Dysregulated T cell expression of TIM3 in multiple sclerosis. <i>J Exp Med<\/i> 203: 1413-1418.","DOI":"10.1084\/jem.20060210"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yang L, Anderson DE, Kuchroo J, Hafler DA (2008) Lack of TIM-3 immunoregulation in multiple sclerosis. <i>J Immunol<\/i> 180: 4409-4414.","DOI":"10.4049\/jimmunol.180.7.4409"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chae SC, Park YR, Shim SC, Yoon KS, Chung HT (2004) The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. <i>Immunol Lett<\/i> 95: 91-95.","DOI":"10.1016\/j.imlet.2004.06.008"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H (2012) SOCS, Inflammation, and Autoimmunity. <i>Front Immunol<\/i> 3: 20.","DOI":"10.3389\/fimmu.2012.00020"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Tanaka K, Ichiyama K, Hashimoto M, Yoshida H, Takimoto T, <i>et al<\/i>. (2008) Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. <i>J Immunol<\/i> 180: 3746-3756.","DOI":"10.4049\/jimmunol.180.6.3746"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Harada M, Nakashima K, Hirota T, Shimizu M, Doi S, <i>et al<\/i>. (2007) Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma. <i>Am J Respir Cell Mol Biol<\/i> 36: 491-496.","DOI":"10.1165\/rcmb.2006-0090OC"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Liu Z, Wang H, Xiao W, Wang C, Liu G, <i>et al<\/i>. (2010) Thyrocyte interleukin-18 expression is up-regulated by interferon-gamma and may contribute to thyroid destruction in Hashimoto&rsquo;s thyroiditis. <i>Int J Exp Pathol<\/i> 91: 420-425.","DOI":"10.1111\/j.1365-2613.2010.00715.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. <i>Nat Immunol<\/i> 8: 942-949.","DOI":"10.1038\/ni1496"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Hayashi F, Watanabe M, Nanba T, Inoue N, Akamizu T, <i>et al<\/i>. (2009) Association of the -31C\/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves&rsquo; disease and the proportion of T helper type 17 cells. <i>Clin Exp Immunol<\/i> 158: 281-286.","DOI":"10.1111\/j.1365-2249.2009.04034.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, <i>et al<\/i>. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. <i>Nat Immunol<\/i> 6: 1123-1132.","DOI":"10.1038\/ni1254"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Mukai T, Hiromatsu Y, Ichimura M, Fukutani T, Kaku H, <i>et al<\/i>. (2006) Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves&rsquo; disease or Graves&rsquo; ophthalmopathy. <i>Thyroid<\/i> 16: 243-248.","DOI":"10.1089\/thy.2006.16.243"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Tavares NA, Santos MM, Moura R, Araujo J, Guimaraes R, <i>et al<\/i>. (2013) Interleukin 18 (IL18) gene promoter polymorphisms are associated with type 1 diabetes mellitus in Brazilian patients. <i>Cytokine<\/i> 62: 286-289.","DOI":"10.1016\/j.cyto.2013.03.004"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Jang JP, Cho WK, Baek IC, Choi EJ, Shin DH, <i>et al<\/i>. (2016) Comprehensive analysis of cytokine gene polymorphisms defines the association of IL-12 gene with ophthalmopthy in Korean children with autoimmune thyroid disease. <i>Mol Cell Endocrinol<\/i> 426: 43-49.","DOI":"10.1016\/j.mce.2016.02.002"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/7\/64_EJ16-0551\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T15:36:04Z","timestamp":1692804964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/7\/64_EJ16-0551\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0551","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}